These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 17546635)
1. Successful treatment of pure red cell aplasia with autologous stem cell transplantation. Park JH; Spitzer T; Kuter DJ Am J Hematol; 2007 Sep; 82(9):812-4. PubMed ID: 17546635 [TBL] [Abstract][Full Text] [Related]
2. Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation. Musso M; Porretto F; Crescimanno A; Polizzi V; Scalone R Bone Marrow Transplant; 2004 Apr; 33(7):769-71. PubMed ID: 14755320 [TBL] [Abstract][Full Text] [Related]
3. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group. Hirokawa M; Sawada K; Fujishima N; Nakao S; Urabe A; Dan K; Fujisawa S; Yonemura Y; Kawano F; Omine M; Ozawa K; Haematologica; 2008 Jan; 93(1):27-33. PubMed ID: 18166782 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation. Müller BU; Tichelli A; Passweg JR; Nissen C; Wodnar-Filipowicz A; Gratwohl A Bone Marrow Transplant; 1999 Jun; 23(11):1205-7. PubMed ID: 10382963 [TBL] [Abstract][Full Text] [Related]
5. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group. Fujishima N; Sawada K; Hirokawa M; Oshimi K; Sugimoto K; Matsuda A; Teramura M; Karasawa M; Arai A; Yonemura Y; Nakao S; Urabe A; Omine M; Ozawa K; Haematologica; 2008 Oct; 93(10):1555-9. PubMed ID: 18641028 [TBL] [Abstract][Full Text] [Related]
7. Successful treatment of acquired pure red cell aplasia (PRCA) by allogeneic peripheral blood stem cell transplantation. Tseng SB; Lin SF; Chang CS; Liu TC; Hsiao HH; Liu YC; Tsai HJ; Chen TP Am J Hematol; 2003 Dec; 74(4):273-5. PubMed ID: 14635209 [TBL] [Abstract][Full Text] [Related]
8. [Pure red cell aplasia in chronic lymphatic leukemia. Successful treatment using immunosuppression]. Svojgrová M; Slechtová J; Koza V; Panzner P; Cepelák V Vnitr Lek; 1990 May; 36(5):495-502. PubMed ID: 2115704 [TBL] [Abstract][Full Text] [Related]
9. Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietin. Martelli M; Ponchio L; Beguin Y; Meloni G; Mandelli F; Cazzola M Haematologica; 1994; 79(5):456-9. PubMed ID: 7843633 [TBL] [Abstract][Full Text] [Related]
10. [Successful gamma-globulin pulse therapy of a young child with acquired pure red cell aplasia]. Kakinuma Y; Sasaki M; Sugita K; Kamimaki I; Kaneko T; Tsuji A Rinsho Ketsueki; 1996 Apr; 37(4):352-7. PubMed ID: 8847808 [TBL] [Abstract][Full Text] [Related]
11. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion. Verholen F; Stalder M; Helg C; Chalandon Y Eur J Haematol; 2004 Dec; 73(6):441-6. PubMed ID: 15522068 [TBL] [Abstract][Full Text] [Related]
12. A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma. Evens AM; Winter JN; Hou N; Nelson BP; Rademaker A; Patton D; Singhal S; Frankfurt O; Tallman MS; Rosen ST; Mehta J; Gordon LI Br J Haematol; 2008 Feb; 140(4):385-93. PubMed ID: 18162124 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation. Fang B; Song Y; Li N; Li J; Han Q; Zhao RC Ann Hematol; 2009 Mar; 88(3):261-6. PubMed ID: 18769919 [TBL] [Abstract][Full Text] [Related]
14. [Successful treatment of idiopathic pure red cell aplasia with antithymocyte globulin]. Soda M; Usuki K; Adachi Y; Kazama H; Iki S; Urabe A Rinsho Ketsueki; 2001 Nov; 42(11):1122-7. PubMed ID: 11808082 [TBL] [Abstract][Full Text] [Related]
15. Delayed spontaneous remission in a child with primary acquired chronic pure red cell aplasia. Khalil A; Elhasid R; Ben Barak A; Ben Arush MW Pediatr Hematol Oncol; 2010 Oct; 27(7):574-80. PubMed ID: 20615070 [TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment: multiple options. Rossert J; Macdougall I; Casadevall N Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv23-26. PubMed ID: 15827054 [TBL] [Abstract][Full Text] [Related]
17. Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin's lymphoma patients receiving autologous hematopoietic stem cell transplantation. Lee MY; Chiou TJ; Hsiao LT; Yang MH; Lin PC; Poh SB; Yen CC; Liu JH; Teng HW; Chao TC; Wang WS; Chen PM Ann Hematol; 2008 Apr; 87(4):285-9. PubMed ID: 17943285 [TBL] [Abstract][Full Text] [Related]
19. Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasia. Mandreoli M; Finelli C; Lopez A; Ascani S; Vianelli N; Baccarani M; Santoro A Am J Kidney Dis; 2004 Oct; 44(4):757-61. PubMed ID: 15384028 [TBL] [Abstract][Full Text] [Related]
20. Prolonged course of pure red cell aplasia after erythropoietin therapy. Nigg L; Schanz U; Ambühl PM; Fehr J; Bachli EB Eur J Haematol; 2004 Nov; 73(5):376-9. PubMed ID: 15458518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]